These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 18631848)

  • 1. Congenital myasthenic syndromes.
    Engel AG
    Handb Clin Neurol; 2008; 91():285-331. PubMed ID: 18631848
    [No Abstract]   [Full Text] [Related]  

  • 2. Refinement of the clinical phenotype in musk-related congenital myasthenic syndromes.
    Mihaylova V; Salih MA; Mukhtar MM; Abuzeid HA; El-Sadig SM; von der Hagen M; Huebner A; Nürnberg G; Abicht A; Müller JS; Lochmüller H; Guergueltcheva V
    Neurology; 2009 Dec; 73(22):1926-8. PubMed ID: 19949040
    [No Abstract]   [Full Text] [Related]  

  • 3. Congenital myasthenic syndromes.
    Harper CM
    Semin Neurol; 2004 Mar; 24(1):111-23. PubMed ID: 15229798
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Congenital myasthenic syndrome: a case report.
    Ceylan A; Tuncer O; Sayin R; Peker E; Caksen H; Sari S
    Genet Couns; 2011; 22(1):75-8. PubMed ID: 21614992
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structural abnormalities of the AChR caused by mutations underlying congenital myasthenic syndromes.
    Beeson D; Webster R; Ealing J; Croxen R; Brownlow S; Brydson M; Newsom-Davis J; Slater C; Hatton C; Shelley C; Colquhoun D; Vincent A
    Ann N Y Acad Sci; 2003 Sep; 998():114-24. PubMed ID: 14592868
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of salbutamol monotherapy in slow-channel congenital myasthenic syndrome caused by a novel mutation in CHRND.
    Tawara N; Yamashita S; Takamatsu K; Yamasaki Y; Mukaino A; Nakane S; Farshadyeganeh P; Ohno K; Ando Y
    Muscle Nerve; 2021 Apr; 63(4):E30-E32. PubMed ID: 33428214
    [No Abstract]   [Full Text] [Related]  

  • 7. Congenital myasthenic syndrome: a brief review.
    Lorenzoni PJ; Scola RH; Kay CS; Werneck LC
    Pediatr Neurol; 2012 Mar; 46(3):141-8. PubMed ID: 22353287
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic heterogeneity and pathophysiological mechanisms in congenital myasthenic syndromes.
    Barišić N; Chaouch A; Müller JS; Lochmüller H
    Eur J Paediatr Neurol; 2011 May; 15(3):189-96. PubMed ID: 21498094
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Congenital myasthenic syndromes.
    Eymard B; Hantaï D; Estournet B
    Handb Clin Neurol; 2013; 113():1469-80. PubMed ID: 23622369
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rapsyn mutations in myasthenic syndrome due to impaired receptor clustering.
    Maselli RA; Dunne V; Pascual-Pascual SI; Bowe C; Agius M; Frank R; Wollmann RL
    Muscle Nerve; 2003 Sep; 28(3):293-301. PubMed ID: 12929188
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Congenital myasthenic syndromes: an update.
    Hantaï D; Nicole S; Eymard B
    Curr Opin Neurol; 2013 Oct; 26(5):561-8. PubMed ID: 23995276
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Congenital myasthenic syndromes: spotlight on genetic defects of neuromuscular transmission.
    Müller JS; Mihaylova V; Abicht A; Lochmüller H
    Expert Rev Mol Med; 2007 Aug; 9(22):1-20. PubMed ID: 17686188
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Congenital Myasthenic Syndromes.
    Iyadurai SJP
    Neurol Clin; 2020 Aug; 38(3):541-552. PubMed ID: 32703467
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Undetermined congenital myasthenic syndromes].
    Nakae M; Sonoda Y
    Ryoikibetsu Shokogun Shirizu; 2001; (36):369-71. PubMed ID: 11596413
    [No Abstract]   [Full Text] [Related]  

  • 15. Novel truncating RAPSN mutations causing congenital myasthenic syndrome responsive to 3,4-diaminopyridine.
    Banwell BL; Ohno K; Sieb JP; Engel AG
    Neuromuscul Disord; 2004 Mar; 14(3):202-7. PubMed ID: 15036330
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quinine sulfate as a therapeutic option in a patient with slow channel congenital myasthenic syndrome.
    Peyer AK; Abicht A; Heinimann K; Sinnreich M; Fischer D
    Neuromuscul Disord; 2013 Jul; 23(7):571-4. PubMed ID: 23688972
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Congenital myasthenic syndromes and transient myasthenia gravis.
    Gajda A; Szabó H; Gergev G; Karcagi V; Szabó N; Endreffy E; Túri S; Sztriha L
    Ideggyogy Sz; 2013 May; 66(5-6):200-3. PubMed ID: 23909021
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Congenital myasthenic syndrome from a
    McLean A; Wilson I
    Pract Neurol; 2024 May; 24(3):238-240. PubMed ID: 37985124
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Congenital myasthenic syndromes.
    Beeson D
    Handb Clin Neurol; 2024; 203():69-88. PubMed ID: 39174255
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Congenital myasthenic syndromes: current diagnostic and therapeutic approaches.
    Schara U; Della Marina A; Abicht A
    Neuropediatrics; 2012 Aug; 43(4):184-93. PubMed ID: 22911480
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.